Dr. Alireza Eghtedar
Claim this profileColorado Blood Cancer Institute
Studies Acute Myeloid Leukemia
Studies Leukemia
11 reported clinical trials
24 drugs studied
Area of expertise
1Acute Myeloid Leukemia
HLA-A positive
HLA-A negative
HLA positive
2Leukemia
HLA-A positive
HLA-A negative
HLA positive
Affiliated Hospitals
Clinical Trials Alireza Eghtedar is currently running
Stem Cell Transplantation
for Leukemia
This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children. Post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate mofetil (MMF) will be used for for graft versus host disease (GVHD) prophylaxis. This trial will study how well this treatment works in patients with hematologic malignancies.
Recruiting1 award Phase 2
SENTI-202
for Blood Cancers
This is an open-label study of the safety, biodynamics, and anti-cancer activity of SENTI-202 (an off-the-shelf logic gated CAR NK cell therapy) in patients with CD33 and/or FLT3 expressing blood cancers, including AML and MDS.
Recruiting1 award Phase 14 criteria
More about Alireza Eghtedar
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Alireza Eghtedar has experience with
- Orca-T
- Azacitidine
- Elotuzumab
- Dexamethasone
- Pomalidomide
- Standard-of-Care
Breakdown of trials Alireza Eghtedar has run
Acute Myeloid Leukemia
Leukemia
Acute Leukemia
Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alireza Eghtedar specialize in?
Alireza Eghtedar focuses on Acute Myeloid Leukemia and Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Alireza Eghtedar currently recruiting for clinical trials?
Yes, Alireza Eghtedar is currently recruiting for 4 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Alireza Eghtedar has studied deeply?
Yes, Alireza Eghtedar has studied treatments such as Orca-T, Azacitidine, Elotuzumab.
What is the best way to schedule an appointment with Alireza Eghtedar?
Apply for one of the trials that Alireza Eghtedar is conducting.
What is the office address of Alireza Eghtedar?
The office of Alireza Eghtedar is located at: Colorado Blood Cancer Institute, Denver, Colorado 80218 United States. This is the address for their practice at the Colorado Blood Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.